← Leaderboards
Joanne Donna Stekler
University Of Washington
$9,601,472
Attributed
$9,601,472
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,792,643 · 5
CDC$3,808,829 · 1
By mechanism
R01$4,204,640 · 2
U01$3,808,829 · 1
R34$699,000 · 1
K23$628,860 · 1
P30$260,143 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Matthew R Golden$9,979,404
- Carey Farquhar$27,772,472
- Lisa M Frenkel$29,105,317
- Joshua T Herbeck$5,177,677
- Marsha Marie Linehan$13,320,438
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsCaringWashingtonReportingPharmaceutical PreparationsClinicInfectionEnrollmentProgramsCollaborationsBaseUniversitiesTest ResultAnti-Retroviral AgentsDetectionDiagnosisFundingTransmission ProcessFrequencies (Time Pattern)Public Health Medicine (Field)Antiretroviral TherapyDesignHiv-1Prevention
Grant awards (28)
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$256,549
U01 · FY2023 · PS · contact PI
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$224,000
U01 · FY2023 · PS · contact PI
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$800,000
U01 · FY2022 · PS · contact PI
SWG 9: eHealth$62,884
P30 · FY2022 · AI · contact PI
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$799,975
U01 · FY2021 · PS · contact PI
SWG 9: eHealth$56,615
P30 · FY2021 · AI · contact PI
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$877,660
U01 · FY2020 · PS · contact PI
SWG 9: eHealth$59,935
P30 · FY2020 · AI · contact PI
The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)$850,645
U01 · FY2019 · PS · contact PI
Interventions to Improve the HIV PrEP Cascade among Methamphetamine Users$233,250
R34 · FY2019 · DA · contact PI
SWG 9: eHealth$45,766
P30 · FY2019 · AI · contact PI
Interventions to Improve the HIV PrEP Cascade among Methamphetamine Users$233,250
R34 · FY2018 · DA · contact PI
SWG 9: eHealth$34,943
P30 · FY2018 · AI · contact PI
Interventions to Improve the HIV PrEP Cascade among Methamphetamine Users$232,500
R34 · FY2017 · DA · contact PI
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection$454,273
R01 · FY2013 · MH · contact PI
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection$516,663
R01 · FY2012 · MH · contact PI
Low-frequency HIV-1 Drug Resistance in Primary HIV-1 Infection$435,873
R01 · FY2012 · AI · contact PI
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection$517,891
R01 · FY2011 · MH · contact PI
Low-frequency HIV-1 Drug Resistance in Primary HIV-1 Infection$436,337
R01 · FY2011 · AI · contact PI
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection$524,392
R01 · FY2010 · MH · contact PI
Low-frequency HIV-1 Drug Resistance in Primary HIV-1 Infection$431,307
R01 · FY2010 · AI · contact PI
Comparisons of Public Health Screening Methods for Acute and Early HIV Infection$458,428
R01 · FY2009 · MH · contact PI
Low-frequency HIV-1 Drug Resistance in Primary HIV-1 Infection$429,476
R01 · FY2009 · AI · contact PI
Primary HIV Infection: the Public Health Perspective$125,772
K23 · FY2009 · AI · contact PI
Primary HIV Infection: the Public Health Perspective$125,772
K23 · FY2008 · AI · contact PI
Primary HIV Infection: the Public Health Perspective$125,772
K23 · FY2007 · AI · contact PI
Primary HIV Infection: the Public Health Perspective$125,772
K23 · FY2006 · AI · contact PI
Primary HIV Infection: the Public Health Perspective$125,772
K23 · FY2005 · AI